SNDX logo

Syndax Pharmaceuticals (SNDX) Working Capital

Annual Working Capital

$522.78 M
+$62.06 M+13.47%

31 December 2023

SNDX Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Working Capital

$355.43 M
-$48.15 M-11.93%

30 September 2024

SNDX Quarterly Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SNDX Working Capital Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--32.0%
3 y3 years+22.2%-16.9%
5 y5 years+1089.1%+708.5%

SNDX Working Capital High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+22.2%-32.0%+5.5%
5 y5 yearsat high+1089.1%-32.0%+708.5%
alltimeall timeat high+2245.3%-32.0%>+9999.0%

Syndax Pharmaceuticals Working Capital History

DateAnnualQuarterly
Sept 2024
-
$355.43 M(-11.9%)
June 2024
-
$403.58 M(+0.1%)
Mar 2024
-
$403.09 M(-22.9%)
Dec 2023
$522.78 M(+13.5%)
$522.78 M(+52.9%)
Sept 2023
-
$341.80 M(-9.8%)
June 2023
-
$378.91 M(-9.3%)
Mar 2023
-
$417.79 M(-9.3%)
Dec 2022
$460.72 M(+7.7%)
$460.72 M(+36.8%)
Sept 2022
-
$336.83 M(-6.8%)
June 2022
-
$361.36 M(-7.2%)
Mar 2022
-
$389.50 M(-8.9%)
Dec 2021
$427.71 M(+52.8%)
$427.71 M(+104.1%)
Sept 2021
-
$209.54 M(-12.1%)
June 2021
-
$238.26 M(-6.3%)
Mar 2021
-
$254.38 M(-9.1%)
Dec 2020
$279.99 M(+536.9%)
$279.99 M(+72.5%)
Sept 2020
-
$162.28 M(-9.5%)
June 2020
-
$179.34 M(+110.0%)
Mar 2020
-
$85.42 M(+94.3%)
Dec 2019
$43.96 M
$43.96 M(-22.3%)
Sept 2019
-
$56.56 M(-17.2%)
DateAnnualQuarterly
June 2019
-
$68.28 M(-16.7%)
Mar 2019
-
$81.97 M(+21.9%)
Dec 2018
$67.24 M(-42.8%)
$67.24 M(-14.7%)
Sept 2018
-
$78.83 M(-7.7%)
June 2018
-
$85.40 M(-16.6%)
Mar 2018
-
$102.40 M(-13.0%)
Dec 2017
$117.64 M(+19.9%)
$117.64 M(+7.2%)
Sept 2017
-
$109.76 M(-10.5%)
June 2017
-
$122.66 M(+42.5%)
Mar 2017
-
$86.07 M(-12.3%)
Dec 2016
$98.14 M(+18.0%)
$98.14 M(-9.2%)
Sept 2016
-
$108.12 M(-10.5%)
June 2016
-
$120.83 M(-6.1%)
Mar 2016
-
$128.73 M(+54.8%)
Dec 2015
$83.16 M(+3863.8%)
$83.16 M(-5.3%)
Sept 2015
-
$87.80 M(+4084.9%)
Dec 2014
$2.10 M(-82.2%)
$2.10 M(-7.0%)
Sept 2014
-
$2.26 M(+310.9%)
June 2014
-
$549.00 K(-92.8%)
Mar 2014
-
$7.67 M(-35.1%)
Dec 2013
$11.81 M(-148.5%)
$11.81 M
Dec 2012
-$24.37 M
-

FAQ

  • What is Syndax Pharmaceuticals annual working capital?
  • What is the all time high annual working capital for Syndax Pharmaceuticals?
  • What is Syndax Pharmaceuticals quarterly working capital?
  • What is the all time high quarterly working capital for Syndax Pharmaceuticals?
  • What is Syndax Pharmaceuticals quarterly working capital year-on-year change?

What is Syndax Pharmaceuticals annual working capital?

The current annual working capital of SNDX is $522.78 M

What is the all time high annual working capital for Syndax Pharmaceuticals?

Syndax Pharmaceuticals all-time high annual working capital is $522.78 M

What is Syndax Pharmaceuticals quarterly working capital?

The current quarterly working capital of SNDX is $355.43 M

What is the all time high quarterly working capital for Syndax Pharmaceuticals?

Syndax Pharmaceuticals all-time high quarterly working capital is $522.78 M

What is Syndax Pharmaceuticals quarterly working capital year-on-year change?

Over the past year, SNDX quarterly working capital has changed by -$167.35 M (-32.01%)